Staar Surgical Co. Stock
€15.91
Your prediction
Staar Surgical Co. Stock
Pros and Cons of Staar Surgical Co. in the next few years
Pros
Cons
Performance of Staar Surgical Co. vs. its peers
Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
---|---|---|---|---|---|---|---|
Staar Surgical Co. | -1.950% | 8.827% | -8.592% | -55.856% | -30.758% | -75.055% | -56.305% |
SI-BONE Inc | -2.990% | -1.220% | -0.613% | 32.787% | 24.615% | - | - |
Orasure Tech | 4.840% | 0.775% | 13.043% | -38.679% | -23.977% | -3.704% | -71.429% |
scPharmaceuticals | 0.330% | 10.114% | 61.145% | -3.228% | 12.901% | -19.427% | -44.576% |
Comments
News

STAAR Surgical Announces Participation in Upcoming Investor Conferences
STAAR Surgical Company (NASDAQ: STAA), the global leader in phakic IOLs with the EVO family of Implantable Collamer® Lenses (EVO ICL™) for vision correction, today announced that management will

STAAR Surgical Announces $30 Million Share Repurchase Authorization
STAAR Surgical Company (NASDAQ: STAA), the global leader in phakic IOLs with the EVO family of Implantable Collamer® Lenses (EVO ICL™) for vision correction, today announced that its Board of

STAAR Surgical Reports First Quarter 2025 Results
STAAR Surgical Company (NASDAQ: STAA), the global leader in phakic IOLs with the EVO family of Implantable Collamer® Lenses (EVO ICL™) for vision correction, today reported results for the first